Maggie Mei-Ki Wong

Maggie Mei-Ki Wong

Auto-generated profile, based on publicly available information

Maggie Mei-Ki Wong

Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2021 in European Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
Angela MorganAngela Morgan
Angela Morgan
RBRuth Braden
Ruth Braden
MWMaggie M. K. Wong
Maggie M. K. Wong
ECEstelle Colin
Estelle Colin
DADavid Amor
David Amor
BBBregje W. van Bon
Bregje W. van Bon

19 April 2021 in European Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
NJNadieh A. Jansen
Nadieh A. Jansen
RBRuth O. Braden
Ruth O. Braden
SSSiddharth Srivastava
Siddharth Srivastava
EOErin F. Otness
Erin F. Otness
GLGaetan Lesca
Gaetan Lesca
BBBregje W. van Bon
Bregje W. van Bon

8 March 2022 in medRxiv
Verified
Preprint
Open access
PDF file
MWMaggie Mk Wong
Maggie Mk Wong
RKRosalie A Kampen
Rosalie A Kampen
RBRuth O Braden
Ruth O Braden
GAGökberk Alagöz
Gökberk Alagöz
MHMichael S Hildebrand
Michael S Hildebrand
SFSimon E Fisher
Simon E Fisher
Germline de novo SETBP1 variants cause clinically distinct and heterogeneous neurodevelopmental disorders. Heterozygous missense variants at a hotspot encoding a canonical degron lead to SETBP1 accumulation and Schinzel-Giedion syndrome (SGS), a rare severe developmental disorder involving multisystem malformations. Heterozygous loss-of-function variants result in SETBP1 haploinsufficiency disorder which is phenotypically much milder than SGS. Following an initial description of four individuals with atypical SGS carrying heterozygous missense variants adjacent to the degron, a few individual cases of variants outside the degron were reported. Due to the lack of systematic investigation of genotype-phenotype associations of different types of SETBP1 variants, and limited understanding of the roles of the gene in brain development, the extent of clinical heterogeneity and how this relates to underlying pathophysiological mechanisms remain elusive, imposing challenges for diagnosis and patient care. Here, we present a comprehensive investigation of the largest cohort to-date of individuals carrying SETBP1 missense variants outside the degron (n=18, including one in-frame deletion). We performed thorough clinical and speech phenotyping with functional follow-up using cellular assays and transcriptomics. Our findings suggest that such variants cause a clinically and functionally variable developmental syndrome, showing only partial overlaps with classical SGS and SETBP1 haploinsufficiency disorder, and primarily characterised by intellectual disability, epilepsy, speech and motor impairment. We provide evidence of loss-of-function pathophysiological mechanisms impairing ubiquitination, DNA-binding and transcription. In contrast to SGS and SETBP1 haploinsufficiency, these effects are independent of protein abundance. Overall, our study provides important novel insights into diagnosis, patient care and aetiology of SETBP1-related disorders.

10 October 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
MWMaggie M. K. Wong
Maggie M. K. Wong
RKRosalie A. Kampen
Rosalie A. Kampen
RBRuth O. Braden
Ruth O. Braden
GAGökberk Alagöz
Gökberk Alagöz
MHMichael S. Hildebrand
Michael S. Hildebrand
SFSimon E. Fisher
Simon E. Fisher
Different types of germline de novo SETBP1 variants cause clinically distinct and heterogeneous neurodevelopmental disorders: Schinzel-Giedion syndrome (SGS, via missense variants at a critical degron region) and SETBP1-haploinsufficiency disorder. However, due to the lack of systematic investigation of genotype-phenotype associations of different types of SETBP1 variants, and limited understanding of its roles in neurodevelopment, the extent of clinical heterogeneity and how this relates to underlying pathophysiological mechanisms remains elusive. This imposes challenges for diagnosis. Here, we present a comprehensive investigation of the largest cohort to date of individuals carrying SETBP1 missense variants outside the degron region (n = 18). We performed thorough clinical and speech phenotyping with functional follow-up using cellular assays and transcriptomics. Our findings suggest that such variants cause a clinically and functionally variable developmental syndrome, showing only partial overlaps with classical SGS and SETBP1-haploinsufficiency disorder. We provide evidence of loss-of-function pathophysiological mechanisms impairing ubiquitination, DNA-binding, transcription, and neuronal differentiation capacity and morphologies. In contrast to SGS and SETBP1 haploinsufficiency, these effects are independent of protein abundance. Overall, our study provides important novel insights into diagnosis, patient care, and aetiology of SETBP1-related disorders.

29 April 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JHJoery den Hoed
Joery den Hoed
MWMaggie M. K. Wong
Maggie M. K. Wong
WCWillemijn J. J. Claassen
Willemijn J. J. Claassen
LHLucía de Hoyos
Lucía de Hoyos
LLLukas Lütje
Lukas Lütje
SFSimon E. Fisher
Simon E. Fisher
Changes in the dynamics of chromatin state that control spatiotemporal gene expression patterns are crucial during brain development. CHD3 is a chromatin remodeler that is highly expressed during neurogenesis and that functions as a core member of the NuRD complex, a large multiprotein complex mediating chromatin state. Genetic disruptions in CHD3 have been implicated in a neurodevelopmental disorder characterized by intellectual disability, macrocephaly and severe speech deficits. To study the roles of CHD3 during early human brain development, we generated induced pluripotent stem cells with heterozygous and homozygous loss-of-function mutations, differentiated them into unguided neural organoids and cortical neurons, and analyzed these by immunohistochemistry, bulk RNA-, single-cell RNA-, and ChIP-sequencing. Loss of CHD3 expression had no detectable effects on early neuroepithelium formation and organoid growth, nor did it significantly affect cell type composition or neuronal differentiation speed. Instead, upon loss of CHD3 , we observed dysregulation of genes related to axon guidance and synapse development across all datasets, identifying a novel role for the protein as a regulator that facilitates neurogenesis, in particular neuronal maturation. Our results based on genetically engineered knockout organoids pave the way for future studies modeling the neurobiological pathways affected in CHD3-related disorder.

23 November 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DGDana Jenny Grönberg
Dana Jenny Grönberg
SCSara Luisa Pinto de Carvalho
Sara Luisa Pinto de Carvalho
NDNikola Dernerova
Nikola Dernerova
PNPhillip Norton
Phillip Norton
MWMaggie Mei-Ki Wong
Maggie Mei-Ki Wong
EMEzequiel Mendoza
Ezequiel Mendoza
Rare de novo heterozygous loss-of-function SETBP1 variants lead to a neurodevelopmental disorder characterized by speech deficits, indicating a potential involvement of SETBP1 in human speech. However, the expression pattern of SETBP1 in brain regions associated with vocal learning remains poorly understood, along with the underlying molecular mechanisms linking it to vocal production. In this study, we examined SETBP1 expression in the brain of male zebra finches, a well-established model for studying vocal production learning. We demonstrated that zebra finch SETBP1 exhibits a greater number of exons and isoforms compared to its human counterpart. We characterized a SETBP1 antibody and showed that SETBP1 colocalized with FoxP1, FoxP2, and Parvalbumin in key song nuclei. Moreover, SETBP1 expression in neurons in Area X is significantly higher in zebra finches singing alone, than those singing courtship song to a female, or non-singers. Importantly, we found a distinctive neuronal protein expression of SETBP1 and FoxP2 in Area X only in zebra finches singing alone, but not in the other conditions. We demonstrated SETBP1´s regulatory role on FoxP2 promoter activity in vitro. Taken together, these findings provide compelling evidence for SETBP1 expression in brain regions to be crucial for vocal learning and its modulation by singing behavior.